NCT00408525View on ClinicalTrials.gov

Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

August 24, 2012

Study Completion Date

August 24, 2012

Conditions
Alzheimer's Disease
Interventions
DRUG

donepezil

donepezil 5 mg tablets, total dose per day 10 mg for 6 week duration of study. Taken once per day.

Trial Locations (1)

37212

Vanderbilt University Medical Center, Nashville

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT00408525 - Donepezil and Brain Activity Patterns in Those at Risk For Alzheimer's Disease | Biotech Hunter | Biotech Hunter